IBUS‐SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative Colitis
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Sarah Fischer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colon, Sigmoid. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The international bowel ultrasound group‐segmental activity score (IBUS‐SAS) is a validated tool with high interobserver agreement for accurately detecting disease activity in Crohn's disease (CD). Here, we addressed whether the IBUS‐SAS is also suitable to assess disease activity in ulcerative colitis (UC).
Methods
The IBUS‐SAS and Limberg scores were determined in the sigmoid colon of patients with UC. The results were correlated to established scores of clinical, endoscopic and histologic disease activity (partial [pMS] and endoscopic [eMS] Mayo‐Score, ulcerative colitis endoscopic index of severity [UCEIS], histologic Nancy index) and/or biomarkers of inflammation (C‐reactive protein [CRP], fecal calprotectin). Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) for IBUS‐SAS and the Limberg score to predict endoscopic and histologic disease activity were computed by receiver operating characteristics (ROC)‐analysis.
Results
Fifty‐eight patients with UC were enrolled. The median IBUS‐SAS was 34.8. It was significantly correlated with pMS, eMS, UCEIS, Nancy index, CRP and fecal calprotectin. On ROC‐analysis, a cut‐off of 15.9 was reached with 100% sensitivity and 80.0% specificity for the prediction of endoscopic activity, resulting in a PPV of 94.7% and an NPV of 100%. The Limberg score performed only slightly worse (100.0%, 60.0%, 89.9%, 100%, respectively). Comparable results were found regarding the Nancy index for sensitivity (93.9% vs. 93.9%), specificity (57.1% vs. 42.9%), PPV (91.4% vs. 88.9%) and NPV (65.7% vs. 59.0%).
Conclusions
This study highlights the potential of IUS for the non‐invasive quantification of disease activity in UC and suggests that the IBUS‐SAS should be considered as a diagnostic tool in trials and real‐world management of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany.
- Department of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
ORCID-Profile: Sarah Fischer
Zitieren
APA
Fischer, S., Fischmann, D., Wilde, J., Vetter, M., Wolf, L., Geppert, C., Atreya, R., Waldner, M., Strobel, D., Neurath, M. F., Haberkamp, S., & Zundler, S. (2025). IBUS‐SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative Colitis. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70053
Vancouver
Fischer S, Fischmann D, Wilde J, Vetter M, Wolf L, Geppert C, et al. IBUS‐SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative Colitis. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70053
BibTeX
@article{Fischer2025,
author = {Fischer, Sarah and Fischmann, David and Wilde, Judith and Vetter, Marcel and Wolf, Laurin and Geppert, Carol and Atreya, Raja and Waldner, Maximilian and Strobel, Deike and Neurath, Markus F and Haberkamp, Sophie and Zundler, Sebastian},
title = {IBUS‐SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative Colitis},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70053}
}
EUVIMED